clinical_trials
FDA Panel Largely Pans Trial Data for Myopia Eye Drops
Confidence86·multiple reportsImportance88NP-EVT-20261103-2CF2085
(MedPage Today) -- The regulatory status of a low-dose atropine eye drop formulation for myopia remained unresolved following a day-long FDA advisory committee meeting, but closing comments did not bode well for SYD-101. The Dermatologic and Ophthalmic...
Read the original at the primary source
FDA Panel Largely Pans Trial Data for Myopia Eye Drops
11/3/2026, 9:50:54 PM
Also on the network: airlinesairports · farmerspulse · foodpulse · indianhealthpulse · indias · keralahealth · naturepulse · travelerpulse
Discussion
ChatsPulse · 0 threads
No discussion yet. Sign in and start the first thread —